« Back to Record
Brandao, M., Reyal, F., Hamy, A. S., & Piccart-Gebhart, M. (2019). Neoadjuvant treatment for intermediate/high-risk HER2-positive and triple-negative breast cancers: No longer an option' but an ethical obligation. ESMO Open, 4(3), e000515. doi:10.1136/esmoopen-2019-000515
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/289616



